Morrison & Foerster LLP
Thiosemicarbazones as anti-virals and immunopotentiators
The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering the compounds.
Novartis Vaccines & Diagnostics, Inc.
C C A C A C C C C C C C C C C C A C C C C C C C C C C C C C C C C C C C C A C C C C C C C C C C A C C C C C C C C C
C07D C07D A61K C07D A61P C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D A61K C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D A61K C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D A61P C07D C07D C07D C07D C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Liana Marie Amy J. Weibo Nicholas Simon Keith B. Zhi-Jie Paul A. Allan S. Nathan Anthony Casey
Lagniton Weiner Wang Valiante Ng Pfister Ni Barsanti Wagman Brammeier Diebes Philbin